@metys-pharma.ch
Metys Pharma. Developing dimiracetam for prevention of chemotherapy-induced neuropathic pain.
π’
Find anything inaccurate?
If you spot any mistakes on this brand profile, report to us.
Brand Logos
View allLogo
PNG
About
Description
Metys Pharma, now a part of Novaremed, is a renowned brand in the field of pharmaceuticals. They specialize in developing dimiracetam, a groundbreaking solution for the prevention of chemotherapy-induced neuropathic pain. With a strong focus on non-opioid chronic pain treatment, Metys Pharma is committed to providing innovative approaches to alleviate pain.
Recently, Novaremed AG, a clinical-stage biopharmaceutical company, acquired Metys Pharmaceuticals AG, along with all its development programs. This acquisition has significantly expanded Novaremed's pipeline, incorporating both clinical and preclinical projects. By adding Metys Pharma's expertise, Novaremed now has a wider spectrum of neuropathic pain indications and can address not only the treatment but also the prevention of pain.
To learn more about this exciting development and access complete information, visit their website at www. novaremed. com.
If you have any inquiries, you can reach out to Novaremed AG at Elisabethenstrasse 18, Basel, Switzerland, or contact them via phone at +41 61 5640297 and email at info@novaremed. com. Metys Pharma and Novaremed AG are dedicated to making a significant impact on the well-being and quality of life for individuals experiencing chronic pain
Company Type
Privately Held
Company Size
2-10
Year Founded
2013
Brand collections
View allLogos
Colors
Fonts
Images
Our mission is to keep every brand on-brand everywhere π
All services online
Top brand categories